Pasithea Therapeutics Corp. (KTTAW) Gross Margin (2022)

Pasithea Therapeutics has disclosed Gross Margin across 1 years of filings, most recently posting 100.54% for Q4 2022.

• In Q4 2022, Gross Margin changed N/A year-over-year to 100.54%; the TTM figure through Dec 2022 stood at 76.74% (changed N/A YoY), while the FY2022 annual figure was 76.74%, up 9143.0% from the prior year.
• Gross Margin came in at 100.54% for Q4 2022 at Pasithea Therapeutics, up from 60.45% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 100.54% in Q4 2022 to a low of 11.19% in Q2 2022.